Validation of mitochondrial biomarkers and immune dynamics in polycystic ovary syndrome

Abstract

AbstractProblemPolycystic ovary syndrome (PCOS), a prevalent endocrine‐metabolic disorder, presents considerable therapeutic challenges due to its complex and elusive pathophysiology.Method of studyWe employed three machine learning algorithms to identify potential biomarkers within a training dataset, comprising GSE138518, GSE155489, and GSE193123. The diagnostic accuracy of these biomarkers was rigorously evaluated using a validation dataset using area under the curve (AUC) metrics. Further validation in clinical samples was conducted using PCR and immunofluorescence techniques. Additionally, we investigate the complex interplay among immune cells in PCOS using CIBERSORT to uncover the relationships between the identified biomarkers and various immune cell types.ResultsOur analysis identified ACSS2, LPIN1, and NR4A1 as key mitochondria‐related biomarkers associated with PCOS. A notable difference was observed in the immune microenvironment between PCOS patients and healthy controls. In particular, LPIN1 exhibited a positive correlation with resting mast cells, whereas NR4A1 demonstrated a negative correlation with monocytes in PCOS patients.ConclusionACSS2, LPIN1, and NR4A1 emerge as PCOS‐related diagnostic biomarkers and potential intervention targets, opening new avenues for the diagnosis and management of PCOS.